相关实验视频
Updated: Jun 11, 2025

05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
506
达帕格利弗洛辛对末期病 (DARE-ESKD-2) 试验的心血管影响:理由和设计
Joaquim Barreto1, Marilia Martins1, Mauro Pascoa2
1Laboratory of Atherosclerosis and Vascular Biology (Aterolab), Faculty of Medical Sciences, University of Campinas (Unicamp), Campinas, Brazil.
Expert opinion on drug safety
|October 8, 2024
概括
这项研究调查了达帕格利弗洛辛是否有利于透析患者的心脏功能,扩展了慢性病的先前发现. 结果可能支持在末期病中使用SGLT2抑制剂.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 达帕格利弗洛辛在预防慢性病 (CKD) 患者心肌功能障碍方面表现出有效性.
- 这种保护作用不论残留的功能,都被观察到.
- 该研究假设这些好处延伸到接受透析的患者.
研究的目的:
- 评估达帕格利弗洛辛对透析患者心肌功能和结构的影响.
- 作为主要终点,评估NT-proBNP水平的变化.
- 探索二次终点,包括心脏成像参数,功能能力和症状.
主要方法:
- DARE-ESKD-2试验是一个正在进行的,单中心的,开放的随机临床试验.
- 80名接受透析超过3个月的成年患者被随机分配1:1接受达帕格利弗洛辛或标准治疗24周.
- 排除标准包括怀孕,肝衰竭,药物过敏和之前使用SGLT2抑制剂.
主要成果:
- 80名参与者完成了患者招生.
- 所有参与者目前正在接受24周的随访期.
- 主要和次要结果数据正在等待分析.
结论:
- 这项试验将为在透析中的末期脏疾病 (ESKD) 患者中SGLT2抑制剂对心肌的影响提供新的见解.
- 这些发现可能支持在ESKD群体中扩大SGLT2抑制剂的使用.
- 该研究旨在为透析患者的心血管风险管理提供基于证据的建议.
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
2
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
2
Chronic Kidney Disease IV: Nursing Management
2
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
2
Heart Failure V: Medical Management
2
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
2
Acute Kidney Injury IV: Diagnostic Studies and Prevention
8
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
8
Acute Kidney Injury V: Interprofessional Care
2
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
2
Chronic Kidney Disease II: Clinical Manifestations
2
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
2

